Related Experiment Video

Updated: Jun 20, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Oncolytic gene therapy for canine cancers: teaching old dog viruses new tricks

M Arendt1, L Nasir, I M Morgan

  • 1Institute of Comparative Medicine, Division of Pathological Sciences, University of Glasgow Faculty of Veterinary Medicine, Glasgow, UK.

Veterinary and Comparative Oncology
|August 21, 2009
PubMed

Insights

Oncolytic viruses, engineered to target cancer cells, show promise for treating canine cancer. Dogs serve as valuable models for human cancer research, with canine viruses being explored for therapeutic applications.

Area of Science:

  • * Veterinary Medicine and Oncology
  • * Molecular Biology and Virology

Background:

  • * Oncolytic virotherapy, the use of viruses to selectively infect and kill cancer cells, has been investigated for decades.
  • * Advancements in molecular biology enable genetic engineering of viruses to enhance their tumor-targeting capabilities.
  • * Canine cancer research benefits from dogs as comparative models for human disease, facilitating proof-of-concept studies.

Purpose of the Study:

  • * To introduce the concept of oncolytic viruses (OVs) in cancer treatment.
  • * To review preliminary efforts in utilizing OVs for canine cancer therapy.
  • * To highlight the potential of canine viruses as oncolytic agents.

Main Methods:

  • * Review of existing literature on oncolytic virotherapy.
  • * Exploration of genetically modified viruses for cancer treatment.
  • * Focus on canine distemper virus and adenovirus as potential oncolytic agents.

Main Results:

  • * Viruses can be engineered to specifically target and destroy cancer cells.
  • * Canine viruses are being investigated for their oncolytic potential in treating canine malignancies.
  • * Preliminary studies suggest feasibility of using OVs in veterinary oncology.

Conclusions:

  • * Oncolytic virotherapy represents a promising approach for cancer treatment.
  • * Canine models offer a valuable platform for advancing OV research for both animal and human applications.
  • * Further investigation into canine viruses as oncolytic agents is warranted for veterinary cancer therapy.

More Related Videos

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors14:55

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors

Published on: December 3, 2013

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...